Maria Celeste Gigliotti

Department of Translational Medical Sciences, University of Naples Federico II, Via Sergio Pansini 5, Naples, 80131, Italy.

3 publications 2021 – 2024 ORCID

What does Maria Celeste Gigliotti research?

Dr. Gigliotti studies how vaccines, particularly the mRNA COVID-19 vaccines, affect patients with hereditary angioedema, a condition characterized by sudden swelling attacks. Her work investigates whether these vaccines could trigger more swelling episodes or complicate disease management in these patients. She found that, despite some initial reactions after vaccination, the overall health and disease control of these patients improved after receiving the vaccine. This research is crucial for understanding vaccine safety in individuals with specific health conditions.

Key findings

  • In Dr. Gigliotti's study, all 31 patients with hereditary angioedema developed protective antibodies against COVID-19 after vaccination.
  • Only a few patients experienced swelling attacks following the first vaccine dose, but the overall attack frequency did not increase.
  • Patients' disease control improved after vaccination, indicating a positive outcome despite the underlying condition.

Frequently asked questions

Does Dr. Gigliotti study COVID-19 vaccines?
Yes, she studies the safety and effectiveness of COVID-19 vaccines in patients with hereditary angioedema.
What conditions does Dr. Gigliotti's research focus on?
Her research primarily focuses on hereditary angioedema, a rare condition that causes sudden swelling.
Is Dr. Gigliotti's work relevant to patients with hereditary angioedema?
Yes, her work is highly relevant as it addresses the safety and effects of COVID-19 vaccination in these patients.

Publications in plain English

Clinical features and potential markers of disease in idiopathic non-histaminergic angioedema, a real-life study.

2024

Immunologic research

Mormile I, Gigliotti MC, Ferrara AL, Gatti R, Spadaro G +4 more

Plain English
This study looked at a rare condition called idiopathic non-histaminergic angioedema (InH-AAE), which causes swelling and doesn’t respond to common allergy medications. Researchers examined 26 patients and found that certain proteins in the blood, specifically the ratio of ANGPT2 to ANGPT1, were altered, indicating issues with blood vessel permeability. Understanding these features can help doctors diagnose this condition faster and develop better treatments, improving patients' quality of life. Who this helps: Patients with idiopathic non-histaminergic angioedema and their doctors.

PubMed

Immunogenicity and Safety of Anti-SARS-CoV-2 mRNA Vaccines in a Cohort of Patients with Hereditary Angioedema.

2023

Vaccines

Mormile I, Gigliotti MC, Petraroli A, Cocchiaro A, Furno A +4 more

Plain English
Researchers gave 31 patients with hereditary angioedema (a rare condition causing sudden swelling attacks) two doses of the Pfizer COVID-19 vaccine to see if the shots would trigger more attacks or cause problems. While a few patients did have swelling attacks shortly after the first shot, the vaccine did not increase attack frequency overall, and patients' disease control actually improved after vaccination. All vaccinated patients developed protective antibodies against COVID-19 just like healthy people did, confirming the vaccine worked in this population.

PubMed

Roles of Immune Cells in Hereditary Angioedema.

2021

Clinical reviews in allergy & immunology

Ferrara AL, Cristinziano L, Petraroli A, Bova M, Gigliotti MC +7 more

Plain English
This study looked at hereditary angioedema (HAE), a rare genetic condition that causes dangerous swelling in the body. Researchers found that immune cells, such as monocytes, granulocytes, and mast cells, play a key role in this condition by producing substances that can increase swelling. Understanding how these immune cells work is important because it could lead to better treatments and prevention strategies for people who suffer from HAE. Who this helps: This helps patients with hereditary angioedema and their doctors.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.